$31.82
-0.31-0.96%
At Close: -
$31.82
00.00%
After Hours: Sep 20, 4:00 PM EDT
15 minutes delayed
Supernus Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Supernus Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-06 | $0.36 | $0.39 | -7.69 % |
Mar 2024 | 2024-05-08 | $0 | $0.38 | -100.0 % |
Dec 2023 | 2024-02-27 | $0.39 | $0.55 | -29.1 % |
Sep 2023 | 2023-11-08 | $-0.29 | $0.13 | -323.1 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-06 | $168.33M | $148.85M | 13.1 % |
Mar 2024 | 2024-05-08 | $143.64M | $145.83M | -1.50 % |
Dec 2023 | 2024-02-27 | $164.31M | $155.03M | 5.99 % |
Sep 2023 | 2023-11-08 | $153.88M | $146.14M | 5.30 % |
Supernus Pharmaceuticals (SUPN) is scheduled to report earnings on November 6, 2024. The last reported earnings were for reported on August 6, 2024 for Q2.
The Actual EPS was $0.36, which missed the estimate of $0.39.
The Actual Revenue was $168.3M, which beat the estimate of $148.8M.
Browse earnings estimates, EPS, and revenue on all stocks.